Table 6.
Projected annual budget and clinical impact of new versus current market share for uterotonics
| 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|
| Total Births | 13,979,677 | 14,124,691 | 14,271,210 | 14,419,249 | 14,568,823 |
| Total Costs ($) | |||||
| Current environment | 1,975,973,855 | 1,996,471,093 | 2,017,180,954 | 2,038,105,644 | 2,059,247,390 |
| New environment | 1,975,920,321 | 1,995,930,198 | 2,015,491,503 | 2,034,415,603 | 2,053,845,363 |
| Budget impact | -53,534 | -540,895 | -1,689,452 | -3,690,041 | -5,402,026 |
| Total Costs (₹) | |||||
| Current environment | 147,506,448,280 | 149,036,567,126 | 150,582,558,253 | 152,144,586,306 | 153,722,817,641 |
| New environment | 147,502,451,954 | 148,996,189,314 | 150,456,440,696 | 151,869,124,773 | 153,319,556,370 |
| Budget impact | -3,996,326 | -40,377,812 | -126,117,556 | -275,461,533 | -403,261,272 |
| Total PPH Events | |||||
| Current environment | 2,633,715 | 2,661,035 | 2,688,639 | 2,716,529 | 2,744,708 |
| New environment | 2,632,219 | 2,645,917 | 2,640,648 | 2,611,835 | 2,592,148 |
| Clinical impact | -1,496 | -15,118 | -47,991 | -104,694 | -152,560 |